Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
5.
Clin Drug Investig ; 30(3): 179-85, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20155990

RESUMEN

BACKGROUND: NSAIDs are widely used to treat fever and pain in children, but their possible role in the progression of some bacterial infections is controversial. OBJECTIVE: This study was performed to analyse reported cases of severe bacterial infection associated with NSAID exposure in children admitted for this reason to a general paediatric department. METHODS: This study was based on the reporting system of hospital admissions for severe bacterial infections in children after NSAID exposure, and followed the recommendations of the European Guidelines of Pharmacovigilance for medicines used in a paediatric population. Data were prospectively collected and reported by active daily surveillance in the department from November 2002 to November 2005. RESULTS: Thirty-two cases of severe bacterial infections (cellulitis, soft tissue abscesses, parapneumonic empyema, necrotizing pneumonia, adenophlegmon [fever and a tender, warm and easily compressible neck mass] and lateral or retropharyngeal abscesses) were identified in children who had received NSAIDs, principally ibuprofen, in an exposure window of 15 days before the beginning of the signs of infection. Staphylococcus aureus, group A streptococci and Streptococcus pneumoniae were identified. Seven (22%) children required surgical treatment, and four (13%) were hospitalized in an intensive care unit. CONCLUSIONS: The frequency of hospitalization for severe bacterial infection as a possible adverse effect of NSAID use was 0.6% (95% CI 0.4, 0.9) of all admissions during the study period. The frequency of severe bacterial infections after exposure to NSAIDs was elevated (one case per month) in the department studied. Further work is necessary to confirm these findings, given the potential for recruitment and protopathic biases in our study.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Infecciones Bacterianas/etiología , Hospitalización/estadística & datos numéricos , Sistemas de Registro de Reacción Adversa a Medicamentos , Infecciones Bacterianas/microbiología , Niño , Preescolar , Femenino , Hospitales Generales/estadística & datos numéricos , Humanos , Lactante , Masculino , Estudios Prospectivos , Infecciones Estafilocócicas/etiología , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/etiología
6.
Fundam Clin Pharmacol ; 32(2): 147-154, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29172254

RESUMEN

The aim of this study was to determine the role of nonsteroidal anti-inflammatory drugs (NSAID) injection on the severity of local infection and the effect on the progression of soft tissue infection (STI).The mouse model of STI with Group A streptococcus (GAS) was developed and treated with diclofenac sodium (DS) intramuscularly. Mice were divided into five groups: administered DS for 48 h before GAS (Group 1), GAS-DS and maintained DS for 48 h (Group 2), DS for 48 h (Group 3), GAS on zero time (Group 4), and control (Group 5). In vitro, a high concentration (40 mg/L) of DS inhibited GAS growth, whereas a lower concentration (0.4 mg/L) was not effective. Sepsis was observed in animals with DS and GAS inoculation (group 1 and 2). Group 4 had statistically significant higher bacterial load than groups 1 and 2. All groups had a higher inflammation rate than the control group. The median of TNF-alpha and mean IL-6 in the groups 1, 2, and 4 was significantly higher than those in the control group. Even if the animals that were treated with DS injection prior to the GAS inoculation had similar inflammation score, similar cytokine levels and low bacterial load in the tissue, they had a rather high rate of sepsis. In conclusion, DS injection prior to bacterial inoculation might predispose to bacteremia and sepsis.


Asunto(s)
Antiinflamatorios no Esteroideos/toxicidad , Diclofenaco/toxicidad , Sepsis/inducido químicamente , Infecciones de los Tejidos Blandos/inducido químicamente , Infecciones Estreptocócicas/inducido químicamente , Streptococcus pyogenes/patogenicidad , Absceso/sangre , Absceso/inducido químicamente , Absceso/microbiología , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Bacteriemia/sangre , Bacteriemia/inducido químicamente , Bacteriemia/microbiología , Carga Bacteriana , Diclofenaco/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Mediadores de Inflamación/sangre , Inyecciones Intramusculares , Interleucina-6/sangre , Ratones Endogámicos BALB C , Sepsis/sangre , Sepsis/microbiología , Sepsis/patología , Infecciones de los Tejidos Blandos/sangre , Infecciones de los Tejidos Blandos/microbiología , Infecciones de los Tejidos Blandos/patología , Infecciones Estreptocócicas/sangre , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/patología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/sangre
7.
Middle East Afr J Ophthalmol ; 24(2): 100-102, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28936055

RESUMEN

To report a rare case of infectious keratitis after collagen cross-linking (CXL) for keratoconus. A 20-year-old male patient underwent CXL for keratoconus in his right eye. Four weeks after the procedure, he reported blurred vision and redness with increasing pain in the treated eye. Ophthalmic examination revealed a corneal epithelial defect with corneal infiltrates that exhibited branching needle-like opacities. The patient was diagnosed with infectious crystalline keratopathy (ICK). Corneal scrapings and culture indicated the presence of Streptococcus sanguinis. The patient was successfully treated with fortified vancomycin and ceftazidime over several weeks. ICK is a potential post-operative complication of CXL that can lead to corneal scarring with a permanent reduction in visual acuity.


Asunto(s)
Colágeno/efectos adversos , Córnea/patología , Reactivos de Enlaces Cruzados/efectos adversos , Infecciones Bacterianas del Ojo/microbiología , Queratitis/microbiología , Queratocono/tratamiento farmacológico , Infecciones Estreptocócicas/microbiología , Colágeno/uso terapéutico , Córnea/efectos de los fármacos , Reactivos de Enlaces Cruzados/uso terapéutico , Infecciones Bacterianas del Ojo/inducido químicamente , Infecciones Bacterianas del Ojo/diagnóstico , Humanos , Queratitis/inducido químicamente , Queratitis/diagnóstico , Masculino , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/diagnóstico , Streptococcus salivarius/aislamiento & purificación , Agudeza Visual , Adulto Joven
8.
Vestn Khir Im I I Grek ; 165(3): 11-4, 2006.
Artículo en Ruso | MEDLINE | ID: mdl-16881166

RESUMEN

An experience with diagnostics and surgical treatment of 291 patients with complicated course of lung cancer is described with special reference to specificities of the clinical course, preoperative management and operation technique. It was shown that the purposeful preoperative management allowed the assessment of the patients, previously thought to be inoperable, to be revised in 25% of cases, and the frequency of postoperative complications and lethality to be reduced to 14 and 3.5% respectively. The 5 year survival of lung cancer patients with paracancrous alterations was 20.7%.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Carcinoma de Pulmón de Células no Pequeñas/cirugía , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/cirugía , Síndromes Paraneoplásicos/patología , Infecciones Estreptocócicas/patología , Neoplasias Torácicas/patología , Carcinoma de Pulmón de Células no Pequeñas/epidemiología , Humanos , Neoplasias Pulmonares/epidemiología , Estadificación de Neoplasias , Síndromes Paraneoplásicos/epidemiología , Complicaciones Posoperatorias/mortalidad , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/epidemiología , Neoplasias Torácicas/epidemiología
9.
Bone Joint J ; 98-B(8): 1027-35, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27482013

RESUMEN

AIMS: Using a systematic review, we investigated whether there is an increased risk of post-operative infection in patients who have received an intra-articular corticosteroid injection to the hip for osteoarthritis prior to total hip arthroplasty (THA). METHODS: Studies dealing with an intra-articular corticosteroid injection to the hip and infection following subsequent THA were identified from databases for the period between 1990 to 2013. Retrieved articles were independently assessed for their methodological quality. RESULTS: A total of nine studies met the inclusion criteria. Two recommended against a steroid injection prior to THA and seven found no risk with an injection. No prospective controlled trials were identified. Most studies were retrospective. Lack of information about the methodology was a consistent flaw. CONCLUSIONS: The literature in this area is scarce and the evidence is weak. Most studies were retrospective, and confounding factors were poorly defined or not addressed. There is thus currently insufficient evidence to conclude that an intra-articular corticosteroid injection administered prior to THA increases the rate of infection. High quality, multicentre randomised trials are needed to address this issue. Cite this article: Bone Joint J 2016;98-B:1027-35.


Asunto(s)
Corticoesteroides/administración & dosificación , Artroplastia de Reemplazo de Cadera/métodos , Osteoartritis de la Cadera/cirugía , Infección de la Herida Quirúrgica/etiología , Corticoesteroides/efectos adversos , Artroplastia de Reemplazo de Cadera/efectos adversos , Infecciones por Escherichia coli/inducido químicamente , Humanos , Inyecciones Intraarticulares , Cuidados Preoperatorios/efectos adversos , Cuidados Preoperatorios/métodos , Infecciones Estafilocócicas/inducido químicamente , Staphylococcus aureus , Infecciones Estreptocócicas/inducido químicamente
10.
Leukemia ; 17(5): 925-30, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12750707

RESUMEN

Infections represent a frequent complication of chemotherapy used for acute myeloid leukaemia (AML) and are associated with important toxicity frequently leading to treatment discontinuation. Acute promyelocytic leukaemia (APL) is a unique AML subset requiring tailored therapy including all-trans retinoic acid and anthracycline-based chemotherapy. We analysed in this study the incidence and type of infections complicating the clinical course of 89 consecutive APL patients receiving the AIDA protocol at a single institution. A total of 179 febrile episodes were registered during induction and consolidation, 52% of which were of unknown origin. Infections were clinically and microbiologically documented in 10.6 and 37.4% of cases, respectively. Coagulase-negative staphylococci represented the major cause of septicaemia (28%) and were more frequently isolated during induction, whereas viridans group streptococci, the second pathogen most frequently isolated from blood (27%), represented the principal pathogen detected during consolidation and were significantly associated with mucositis. Gram-negative bacteria accounted for 33.3% of all blood isolates. Fungal infections were only occasionally observed. Bloodstream infections in APL patients were compared with those documented in 271 consecutive patients affected by other subtypes of AML. The incidence of total septicaemia episodes, of staphylococcal bacteraemias and of fungaemias was significantly higher in patients with other AMLs. Empirical antibiotic therapy with ceftriaxone plus amikacin was effective in 73% of APL cases, most of the remaining cases being successfully managed by the addition of teicoplanin. One single death apparently related to infectious complication was recorded. Overall, infections led to antileukaemic treatment withdrawal in six patients, five of whom currently remain in haematologic remission for 13-106 months. These results indicate that a particular pattern of infections is observed in APL patients receiving ATRA plus anthracycline-based chemotherapy and that these appear to be effectively counteracted by standard management.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Bacteriemia/inducido químicamente , Idarrubicina/efectos adversos , Leucemia Promielocítica Aguda/tratamiento farmacológico , Infecciones Estafilocócicas/inducido químicamente , Infecciones Estreptocócicas/inducido químicamente , Tretinoina/efectos adversos , Adolescente , Adulto , Anciano , Amicacina/uso terapéutico , Antibacterianos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bacteriemia/tratamiento farmacológico , Ceftazidima/uso terapéutico , Niño , Preescolar , Quimioterapia Combinada , Femenino , Fiebre/microbiología , Bacterias Grampositivas/aislamiento & purificación , Humanos , Idarrubicina/uso terapéutico , Lactante , Masculino , Persona de Mediana Edad , Inducción de Remisión , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/tratamiento farmacológico , Tretinoina/uso terapéutico
12.
Vaccine ; 33(30): 3440-3, 2015 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-26025806

RESUMEN

The differentiation of live attenuated vaccine strains from their progenitor and wild-type counterparts is important for ongoing surveillance of product safety and improved guidelines on their use. We utilised a genome sequencing approach to confirm that two cases of strangles in previously healthy horses that had received the Pinnacle I. N. vaccine (Zoetis) were caused by the vaccine strain. Our data shed new light on the safety of this vaccine and suggest that factors beyond the maturity of the animal's immune system influence the development of adverse reactions.


Asunto(s)
Vacunas Bacterianas/efectos adversos , Enfermedades de los Caballos/inducido químicamente , Infecciones del Sistema Respiratorio/veterinaria , Infecciones Estreptocócicas/veterinaria , Vacunación/efectos adversos , Animales , Vacunas Bacterianas/administración & dosificación , ADN Bacteriano/química , ADN Bacteriano/genética , Contaminación de Medicamentos , Genoma Bacteriano , Caballos , Infecciones del Sistema Respiratorio/inducido químicamente , Análisis de Secuencia de ADN , Infecciones Estreptocócicas/inducido químicamente , Streptococcus equi
13.
Praxis (Bern 1994) ; 104(3): 151-4, 2015 Jan 28.
Artículo en Alemán | MEDLINE | ID: mdl-25626384

RESUMEN

We present the case of a 63 year old man who died of severe septic shock in the setting of agranulocytosis induced by dipyrone (metamizole). The patient had previously developed agranulocytosis after dipyrone exposure 18 months prior to this. The case illustrates the seriousness of dipyrone-induced agranulocytosis, highlights the risks associated with re-exposure and underlines the need for excellent communication between treating physicians and their patients. The possible underlying mechanisms, epidemiology and management of dipyrone-induced agranulocytosis are discussed.


Asunto(s)
Agranulocitosis/inducido químicamente , Antiinflamatorios no Esteroideos/toxicidad , Dipirona/toxicidad , Infecciones Oportunistas/inducido químicamente , Polineuropatías/tratamiento farmacológico , Choque Séptico/inducido químicamente , Infecciones Estreptocócicas/inducido químicamente , Streptococcus pyogenes , Agranulocitosis/diagnóstico , Antiinflamatorios no Esteroideos/administración & dosificación , Dipirona/administración & dosificación , Resultado Fatal , Humanos , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica/inducido químicamente , Insuficiencia Multiorgánica/diagnóstico , Infecciones Oportunistas/diagnóstico , Recurrencia , Retratamiento , Choque Séptico/diagnóstico , Infecciones Estreptocócicas/diagnóstico
14.
Neuroradiol J ; 28(3): 274-7, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26246095

RESUMEN

Pediatric cerebral sinovenous thrombosis (CSVT) is associated with high morbidity and mortality. Severe long-term sequelae are reported in up to 48% of children. The most frequent location of CSVT in children is the superficial venous system. We present the neuroimaging findings using both computed tomography and magnetic resonance imaging (MRI) in a 10-year-old child with extensive superficial CSVT. Our report aims to stress the importance of awareness of risk factors in suspecting and rapidly diagnosing CSVT. The application of targeted conventional and advanced MRI sequences is the diagnostic tool of choice in children at risk of or with clinically suspected CSVT.


Asunto(s)
Enfermedad de Crohn/tratamiento farmacológico , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Meningitis Bacterianas/diagnóstico , Otitis Media/diagnóstico , Trombosis de los Senos Intracraneales/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Niño , Enfermedad de Crohn/complicaciones , Femenino , Humanos , Imagen por Resonancia Magnética , Meningitis Bacterianas/inducido químicamente , Meningitis Bacterianas/complicaciones , Otitis Media/inducido químicamente , Otitis Media/complicaciones , Trombosis de los Senos Intracraneales/complicaciones , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/complicaciones , Streptococcus anginosus/aislamiento & purificación
15.
Eur J Cancer ; 39(9): 1284-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12763218

RESUMEN

Viridans streptococci (VS) are an increasing cause of bacteraemia in neutropenic patients with cancer. Case-control studies of predisposing factors for acquisition of this infection in children are not published. Between January 1989 and December 1999, 168 episodes of bacteraemia in 161 children with fever and neutropenia of haemato-oncology origin were analysed. 15 cases (9%) in 15 patients were caused by VS. Each case patient was compared with 6 matched control patients; 2 with other Gram-positive cocci (group 2), 2 with gram-negative bacilli bacteraemia (group 3) and two children with fever and neutropenia without bacteraemia (group 4). The median age of patients was 4.1 years (range: 2-15 years). 87% of children had acute leukaemia or lymphomas. Pneumonia was the predominant clinical focus (70%). Shock was observed in 13% of patients. ARDS was observed in one child who died of this complication. Multivariate analysis of risk factors for the development of VS bacteraemia showed that two factors were independent predictors: high doses of cytosine-arabinoside (ARA-C) as part of the chemotherapy treatment (Odds Ratio (OR): 9.3; Confidence Interval (CI) 1.56-55.5) (P<0.014) and the presence of pneumonia (OR: 1.36: CI 2.27-81.9) (P<0.0043). We propose that further studies are warranted to confirm these results.


Asunto(s)
Bacteriemia/etiología , Fiebre/inducido químicamente , Neoplasias/complicaciones , Neutropenia/inducido químicamente , Infecciones Estreptocócicas/inducido químicamente , Estreptococos Viridans , Adolescente , Antimetabolitos Antineoplásicos/efectos adversos , Estudios de Casos y Controles , Niño , Preescolar , Citarabina/efectos adversos , Femenino , Fiebre/microbiología , Humanos , Lactante , Masculino , Análisis Multivariante , Neoplasias/tratamiento farmacológico , Neutropenia/microbiología , Estudios Retrospectivos , Factores de Riesgo
16.
Infect Dis Clin North Am ; 15(2): 423-32, viii, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11447704

RESUMEN

Patients receiving chronic steroids have an increased susceptibility to many different types of infections. The risk of infection is related to the dose of steroid and the duration of therapy. Although pyogenic bacteria are the most common pathogens, chronic steroid use increases the risk of infection with intracellular pathogens such as Listeria, many fungi, the herpes viruses, and certain parasites. Clinicians should consider both common and unusual opportunistic infections in patients receiving chronic steroids.


Asunto(s)
Corticoesteroides/efectos adversos , Infecciones Oportunistas/inducido químicamente , Corticoesteroides/administración & dosificación , Humanos , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/prevención & control , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/prevención & control , Streptococcus pyogenes
17.
Diagn Microbiol Infect Dis ; 2(3 Suppl): 85S-90S, 1984 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-6086221

RESUMEN

The third-generation cephalosporins as a group are characterized by spectra of activity that are the broadest of the currently available antibiotics (Farber and Moellering, 1982). These agents provide excellent coverage of infections due to Enterobacteriaceae. They also exhibit good (but variable) activity against a number of "nonfermentors" such as Pseudomonas aeruginosa, and many of them are likewise active against anaerobes, including Bacteroides fragilis (Farber and Moellering, 1982). As a class, the third generation cephalosporins are less active against gram-positive organisms, but in spite of this they have been clinically effective against infections due to S. aureus and many other gram-positive cocci (Saito, 1982). Enterococci, however, have proven to be a difficult organism for the third-generation cephalosporins. None of the presently available compounds exhibits very good activity against these organisms in vitro (Fass, 1983). Given this fact and the broad spectrum of activity of these compounds against other organisms, there is a significant potential for enterococcal superinfection in patients treated with the third-generation cephalosporins. Indeed, serious enterococcal infection has clearly been documented in patients treated with some third-generation cephalosporins (Moellering, 1982; Yu, 1981). Although none of the presently available third-generation cephalosporins exhibits therapeutically useful activity against enterococci, currently available data suggest that there may be differences among these compounds in their ability to cause (or prevent) this complication. For instance, there are more published reports of enterococcal superinfection in patients treated with moxalactam than in patients receiving the other third-generation cephalosporins.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Cefotaxima/farmacología , Streptococcus/efectos de los fármacos , Sangre , Cefotaxima/efectos adversos , Cefotaxima/uso terapéutico , Medios de Cultivo , Farmacorresistencia Microbiana , Humanos , Pruebas de Sensibilidad Microbiana/métodos , Infecciones Estreptocócicas/inducido químicamente
18.
J Pediatr Orthop B ; 11(2): 117-20, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11943984

RESUMEN

Two cases of bacterial adductor myositis that presented as painful hips in boys aged 4 and 9 years are reported. Clinically, there was severe pain and a high pyrexia, a raised C-reactive protein and positive blood cultures but a negative hip ultrasound. Urgent magnetic resonance imaging demonstrated changes throughout the adductor muscles in keeping with bacterial myositis. Both boys settled with intravenous antibiotic therapy. We propose that magnetic resonance imaging is a valuable tool in the assessment of infection around the hip and should be indicated when other investigations have excluded a septic arthritis but the child remains unwell.


Asunto(s)
Artralgia/etiología , Artritis Infecciosa/diagnóstico , Miositis/diagnóstico , Infecciones Estafilocócicas/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Antibacterianos/administración & dosificación , Niño , Preescolar , Diagnóstico Diferencial , Estudios de Seguimiento , Articulación de la Cadera/microbiología , Articulación de la Cadera/fisiopatología , Humanos , Imagen por Resonancia Magnética , Masculino , Miositis/complicaciones , Miositis/tratamiento farmacológico , Infecciones Estafilocócicas/complicaciones , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/tratamiento farmacológico , Resultado del Tratamiento
19.
Int J Clin Pract Suppl ; (135): 50-3, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12723748

RESUMEN

This paper describes two studies in children with fever in which the safety of ibuprofen was compared with that of paracetamol. The Boston University Fever Study aimed to assess the risk of rare but serious adverse events in febrile children. There were 795 admissions among 84,192 children during the study. There were no significant differences between the drugs in the risk of admission or the risk of secondary endpoints (admissions for asthma or cellulitis, or physician visits for abdominal pain or dyspepsia) and no evidence of clinically significant impairment of renal function. However, ibuprofen was associated with a significantly lower risk of physician visits for asthma: the incidence associated with ibuprofen was 3.0% (CI95% 2.1, 4.1) compared with 5.1% (CI95% 3.5, 7.1) for paracetamol (P = 0.02). The second study was a case control study to investigate a possible association between antipyretic medication, varicella infection and necrotising fasciitis. We identified 52 children aged under 19 years who were admitted to hospital with varicella and Group A streptococcal infection and 172 matched controls with uncomplicated varicella. The risk of invasive Group A streptococcal infection was associated with demographic and environmental factors and persistent high fever. There was no association with the use of ibuprofen or paracetamol alone, but the use of both agents was significantly associated with streptococcal infection. These studies demonstrate that children with fever tolerate treatment with ibuprofen as well as treatment with paracetamol. Neither agent is associated with an increased risk of necrotising soft tissue infections.


Asunto(s)
Acetaminofén/efectos adversos , Analgésicos no Narcóticos/efectos adversos , Fiebre/tratamiento farmacológico , Ibuprofeno/efectos adversos , Antiinflamatorios no Esteroideos/efectos adversos , Asma/inducido químicamente , Niño , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Infecciones Estreptocócicas/inducido químicamente , Suspensiones , Resultado del Tratamiento
20.
Presse Med ; 30(18): 892-5, 2001 May 19.
Artículo en Francés | MEDLINE | ID: mdl-11413843

RESUMEN

BACKGROUND: In order to evaluate occurrence and risk factors for wound infection (WI) in head and neck uncontaminated surgery, we carried out a prospective study. METHODS: From january 1997 through january 1999, we prospectively evaluated 212 wounds of all patients having uncontaminated head and neck surgery at the Oscar Lambret Cancer Center (neck dissections, parotidectomies, thyroidectomies, explorative cervicotomies, cutaneous resections). No antibiotic prophylaxis was given. WI was defined as a wound with pus. Statistical evaluation was performed using the chi 2 test. In univariate analysis, differences were considered significant p < 0.05. RESULTS: The overall WI rate was 6.6% (14/212). In univariate analysis, previous chemotherapy is the only risk factor for WI were: (p < 0.00001). Multivariate analysis was not performed. CONCLUSION: Like other cancer locations, chemotherapy was a major risk factor for WI. In these cases, a phase ill trial could confirm efficacy of standard antibiotic.


Asunto(s)
Antineoplásicos/efectos adversos , Terapia Neoadyuvante , Infecciones Oportunistas/inducido químicamente , Neoplasias de Oído, Nariz y Garganta/tratamiento farmacológico , Infección de la Herida Quirúrgica/inducido químicamente , Adulto , Anciano , Antineoplásicos/uso terapéutico , Femenino , Humanos , Infecciones por Klebsiella/inducido químicamente , Infecciones por Klebsiella/diagnóstico , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/diagnóstico , Neoplasias de Oído, Nariz y Garganta/cirugía , Estudios Prospectivos , Factores de Riesgo , Infecciones Estafilocócicas/inducido químicamente , Infecciones Estafilocócicas/diagnóstico , Infecciones Estreptocócicas/inducido químicamente , Infecciones Estreptocócicas/diagnóstico , Streptococcus agalactiae , Infección de la Herida Quirúrgica/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA